NO sensitizes rat hepatocytes to proliferation by modifying S-adenosylmethionine levels by Garcia-Trevijano, E.R. (Elena R.) et al.
GASTROENTEROLOGY 2002;122:1355-1363 
NO Sensitizes Rat Hepatocytes to Proliferation by Modifying 
S-Adenosylmethionine Levels 
ELENA R. GARCiA-TREVIJANO, MARIA L. MARTiNEZ-CHANTAR, M. UJUE LATASA, 
JOSI~ M. MATO, and MATiAS A. AVILA 
Divisi6n de Hepatologia y Terapia G6nica, Departamento de Medicina Interna, Facultad de Medicina, Universidad e Navarra, 
Pamplona, Spain 
Background & Aims: Liver regeneration is a fundamen- 
tal response of this organ to injury. Hepatocyte prolifer- 
ation is triggered by growth factors, such as hepatocyte 
growth factor. However, hepatocytes need to be primed 
to react to mitogenic signals. It is known that nitrous 
oxide (NO), generated after partial hepatectomy, plays 
an important role in hepatocyte growth. Nevertheless, 
the molecular mechanisms behind this priming event 
are not completely known. S-adenosylmethionine 
(AdoMet) synthesis by methionine adenosyltransferase 
is the first step in methionine metabolism, and NO 
regulates hepatocyte S-adenosylmethionine levels 
through specific inhibition of this enzyme. We have stud- 
ied the modulation of hepatocyte growth factor-induced 
proliferation by NO through the regulation of S-adeno- 
sylmethionine levels. Methods: Studies were conducted 
in cultured rat hepatocytes isolated by collagenase per- 
fusion, which triggers NO synthesis. Results: The mito- 
genic response to hepatocyte growth factor was blunted 
when inducible NO synthase was inhibited; this process 
was overcome by the addition of an NO donor. This 
effect was dependent on methionine concentration in 
culture medium and intracellular S-adenosylmethionine 
levels. Accordingly, we found that S-adenosylmethionine 
inhibits hepatocyte growth factor-induced cyclin D1 and 
D2 expression, activator protein 1 induction, and hepa- 
tocyte proliferation. Conclusions: Together our findings 
indicate that NO may switch hepatocytes into a hepato- 
cyte growth factor-responsive state through the down- 
regulation of S-adenosylmethionine levels. 
L iver regeneration after tissue damage is a fundamen- tal feature of this organ that likely evolved as a 
defense mechanism against food-borne toxic insults3 ,2 
Experimentally, this response can be induced by the 
surgical removal of approximately 70% of the liver tissue 
(partial hepatectomy [PH]), 3 which triggers the prolif- 
eration of the remaining parenchymal cells that divide 
once or twice, quickly restoring the original iver mass. 1,2 
Serial hepatocyte transplantation experiments have evi- 
denced the enormous proliferative potential of this cell 
type, which exceeds that of hematopoietic precursor 
cells. 4 Much effort has been dedicated to the elucidation 
of the mechanisms that trigger hepatocyte proliferation 
after PH. The role of growth factors, such as hepatocyte 
growth factor (HGF), in the mitogenic response of hepa- 
tocytes after PH has been clearly established. 1,2 However, 
quiescent hepatocytes in normal liver are not ready to 
respond to proliferative stimuli, and need to be primed 
to respond to the mitogenic signals conveyed by HGF 
and other growth factors. 1,2 Inducible nitric oxide syn- 
thase (iNOS) expression and NO production are induced 
early after PH. 5 This response must be important because 
inhibition of NO production after PH impairs hepato- 
cyte DNA synthesis, 5 and iNOS knockout mice display 
abnormal liver regeneration and enhanced hepatocellular 
apoptosis. 6 The mechanisms behind these effects of NO 
in regenerating liver cells are not completely known. 
One of the best characterized targets for NO in the 
hepatocyte is methionine adenosyltransferase (MAT), the 
enzyme responsible for the conversion of methionine into 
S-adenosylmethionine (AdoMet). vTwo genes encode for 
MAT: MAT1A and MAT2A; MAT1A is the gene pre- 
dominantly expressed in the adult liver, whereas 
MAT2A expression is widely distributed. 8 We have pre- 
viously shown that the activity of MAT I/III, the product 
of MATIA, is specifically inhibited in vitro and in vivo 
by NO through S-nitrosylation of cysteine 121, a posi- 
tion occupied by glycine in MAT II, the product of 
MAT2A, leading to reduced hepatocyte AdoMet con- 
tents. 9-12 Cellular levels of AdoMet seem to be related to 
the differentiation status of the hepatocyte. In this re- 
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gard, quiescent and proliferating hepatocytes display dif- 
ferent AdoMet contents, being lower in the growing 
cells. This has been observed in rat liver after PH, where 
AdoMet levels are dramatically reduced shortly after the 
intervention, coinciding with the onset of DNA synthe- 
sis and the induction of early-response genes. 13 When 
this decrease in AdoMet after PH was prevented by the 
intraperitoneal administration of AdoMet, hepatocyte 
DNA synthesis was inhibited. 14,15 Additionally, exoge- 
nous addition of AdoMet to cultured rat hepatocytes 
inhibits HGF-induced gene expression and the growth of 
hepatoma cells in culture. .6,1v This notion has received 
further support when MAT1A knockout mice became 
available. In these animals, hepatic AdoMet levels are 
reduced by 75% of wild-type levels, and the expression 
of growth- and dedifferentiation-related g nes (such as 
the proliferating cell nuclear antigen and ot-fetoprotein) 
is markedly induced. ~8 Accordingly, these mice show 
enhanced liver growth. TM 
Taken together, these observations have led us now to 
postulate that changes in hepatocyte AdoMet levels, 
through the inhibitory effect of NO on MAT I/I I I  activ- 
ity, could contribute to switch the hepatocyte into an 
HGF-responsive state. In the present report, we have 
evaluated this hypothesis in cultured rat hepatocytes, 
taking advantage of the induction of iNOS expression 
that occurs during collagenase perfusion of rodent liver.~9.2° 
Materials and Methods 
AdoMet, sulfate-p-toluenesulfonate s l , was from Eu- 
ropharma (Madrid, Spain) (produced by Knoll, Milan, Italy). 
[3H]Thymidine (25 Ci/mmol) was from Amersham (Little 
Chalfont, UK). Human recombinant HGF and transforming 
growth factor-o~ (TGF~x) were from Calbiochem (Darmstadt, 
Germany). S-nitroso-N-acetylpenicillamine (SNAP), N G- 
monomethyl-l--arginine methyl ester (L-NAME), and all other 
chemicals, otherwise stated, were from Sigma (St. Louis, MO). 
All antibodies and the mutant AP1 oligonucleotide were from 
Santa Cruz Biotechnology (Santa Cruz, CA), and their refer- 
ences were as follows: cyclin D1 sc-450, cyclin D2 sc-593, 
phospho ERK 1/2 sc-7383, actin sc-8432, c-Fos sc-52x, c-Jun 
sc-45x, Fral sc-183x, JunB sc-46x, JunD sc-74x. 
Isolation and Culture of Rat Hepatocytes 
Hepatocytes were isolated from male Wistar rats 
(200 g) by collagenase perfusion (Gibco-BRL, Paisley, UK), as 
described previously. 21Cells were plated onto collagen-coated 
6-well dishes (type I collagen from rat tail; Collaborative 
Biomedical, Bedford, MA), 106 cells per well. Cultures were 
maintained in minimal essential medium supplemented with 
5% fetal bovine serum, nonessential mino acids, 2 mmol/L 
glutamine, and antibiotics (all from Gibco-BRL). After a 
6-hour incubation, culture medium was removed and cells 
were refed the same medium without fetal bovine serum, 
supplemented with 1 mmol/L L-methionine to preserve 
MAT1A expression 22 and, where indicated, 1 mmol/L 
L-NAME, and further incubated for 18 hours before the onset 
of treatments. Cell viability was measured by trypan blue 
exclusion and by 3-[4,5-dimethylthioazol-2-yl]-2,5-diphe- 
nyltetrazolium bromide assay, no significant differences were 
observed at any time between controls and any of the treat- 
ments performed. Animals were treated humanely and accord- 
ing to our institution's guidelines for the use of laboratory 
animals. 
Assay of DNA Synthesis 
For DNA synthesis experiments, hepatocytes were 
plated at a density of 3 × 104 cells/well in collagen-coated, 
96-well, flat-bottomed plates in minimal essential medium 
supplemented with 5% fetal bovine serum and cultured as 
described previously. Before HGF (25 ng/mL) addition, me- 
dium was replaced by fresh medium containing increasing 
concentrations of L-methionine or AdoMet and, where indi- 
cated, 200 ~mol/L SNAP and 1 mmol/L L-NAME. An 8-hour 
pulse of [~H]thymidine (1 ~Ci/well) started 20 hours after 
HGF addition. Cells were harvested and thymidine incorpo- 
ration was determined in a scintillation counter. 
Determination of MAT Activity and AdoMet 
Content in Cultured Hepatocytes 
Hepatocytes (3 × 106 cells) were lysed and MAT 
activity was assayed as described previously. 23 For the deter- 
mination of AdoMet levels in hepatocytes, cultures were 
washed with saline and then cells (3 × 106) were lysed and 
deproteinized as described. 1° AdoMet contents were deter- 
mined by reverse-phase high-performance liquid chromatog- 
raphy as described. 1° 
Immunoblot Analysis 
For Western blot analysis, hepatocytes were homoge- 
nized as previously described. 22Equal amounts of protein were 
subjected to 10% sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. Proteins were transferred to nitrocellulose 
membranes, iNOS, cyclin D1, cyclin D2, c-Jun, c-Fos, JunB, 
JunD, Fral, and phosphoextracellular signal-regulated kinase 
1/2 (ERK1/2) were detected by using the corresponding anti- 
bodies and secondary horseradish peroxidase-conjugated anti- 
bodies. Blots were developed by enhanced chemoluminescenee 
(Dupont, Boston, MA). Equal loading of the gels was assessed 
with an antibody specific for actin. 
Nuclear Protein Extraction and 
Electrophoretic Mobility Shift Assays 
Nuclear proteins from control and treated hepatocytes 
were isolated as described. 24An oligonucleotide containing the 
activating protein 1 (AP1) consensus sequence (5'-TTC- 
CGGGTGACTCATCAAGCG-3') (Promega, Madison, WI), 
was labeled with (~/32p) adenosine triphosphate by using T4 
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polynucleotide kinase (Roche Diagnostics, Barcelona, Spain). A 
Binding reactions were performed as described. 24 DNA-pro- 
tein complexes were separated from unbound probe by elec- 
trophoresis on a 6% polyacrylamide g l. Complexes formed 
were identified by autoradiography of the dried gels. Specific- 
ity and identity of the complexes were assessed by competition 
and supershift studies. 
Statistics 
Data are the means + SEM of at least 3 independent 
experiments. Statistical significance was estimated with the 
Student test. A P value of less than 0.05 was considered B 
significant. 
Results 
The perfusion of rat liver with collagenase pro- 
motes iNOS expression and NO relqase, 19,2° In agree- 
ment with these reports we also observed the induction 
of iNOS in isolated hepatocytes. Under these experimen- 
tal conditions we tested the effect of the iNOS inhibitor 
L-NAME on the mitogenic activity of HGF in cultured 
rat hepatocytes. As shown in Figure 1A, in the presence 
of L-NAME the proliferative response licited by HGF 
was markedly inhibited. Interestingly, this inhibition 
was overcome when cells were simultaneously treated 
with the NO donor SNAP. These observations suggested 
that NO was interacting with some target or targets in 
the hepatocyte, and that as a consequence the cell would 
turn into an HGF-responsive state. As previously men- 
tioned, MAT I/III is one of the best characterized targets 
of NO in the hepatocyte. 9 12 L-methionine, together 
with adenosine triphosphate, is the substrate of MAT 
I/III in the synthesis of AdoMet, and this reaction is 
inhibited by NO. 12 When we tested the mitogenic effect 
of HGF in cells treated with L-NAME in the presence of 
increasing concentrations of L-methionine, we observed 
that the inhibitory effect of L-NAME was dependent on 
the concentration of this amino acid in the culture me- 
dium, whereas D-methionine (1 mmol/L) had no effect 
(Figure 1B). 
Because the first step in methionine metabolism is its 
conversion into AdoMet, and NO reduces hepatocyte 
AdoMet content, 12 we determined the effect of t-NAME 
on hepatocyte MAT I/III activity and AdoMet levels 
under the same culture conditions used for the DNA 
synthesis experiments. We found that inhibition of NO 
synthesis by L-NAME (24-hour treatment) resulted in 
increased MAT I/Ill activity (from 109.3 + 9.4 to 
161.2 + 6.3 pmol • min -1 • mg -1 of protein, P < 0.01) 
and AdoMet levels (from 83.0 + 2.0 to 103.4 + 0.1 
pmol/mg of protein, P < 0.05). We subsequently ana- 
lyzed the effect of AdoMet on the mitogenic action of 
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Figure 1, (A) HGF-induced DNA synthesis in isolated rat hepatocytes 
depends on iNOS activity, iNOS is induced in hepatocytes isolated by 
collagenase perfusion of rat liver (inset shows Western blot). DNA 
synthesis was measured as [3H]thymidine incorporation in hepato- 
cytes cultured in 1 mmol/L L-methionine and treated with HGF (25 
ng/mL for 28 hours), in the presence or absence of L-NAME (1 
mmol/L). The NO donor SNAP (200 i~mol/L) reversed the inhibitory 
effect of L-NAME on hepatocyte proliferation. *P < 0.01 with respect 
to cells treated with HGF Jn the absence of L-NAME and cells treated 
with HGF in the presence of L-NAME plus SNAP. (B) In the presence of 
the iNOS inhibitor L-NAME (1 mmol/L), HGF-indueed DNA synthesis in 
cultured rat hepatocytes, measured as [3H ]thymidine incorporation, is 
dose-dependently inhibited by the concentration of L-methionine (but 
not D-methionine) in culture medium. *P < 0.05, **P  < 0.01 with 
respect to cells treated with HGF and 0.015 mmol/L L-methionine. 
HGF in cultured rat hepatocytes and found that AdoMet 
inhibited HGF-induced cell proliferation in a dose-de- 
pendent fashion (Figure 2A, left panel). Additionally, the 
permissive ffect of SNAP on HGF-induced DNA syn- 
thesis that was observed in the presence of L-NAME was 
counteracted by the addition of AdoMet (4 mmol/L) 
(Figure 2A, right panel). The inhibitory effect of AdoMet 
(4 mmol/L) on HGF-induced DNA synthesis could be 
observed at different ime points, as shown in Figure 2B. 
The inhibitory effect of L-NAME (1 mmol/L) on he- 
patocyte proliferation was extended to other hepatocyte 
mitogens uch as TGFct. Figure 3A shows how, in the 
presence of 1 mmol/L L-methionine, TGFci-induced 
DNA synthesis was blunted when L-NAME was present 
in the incubation medium. Similarly to what was ob- 
served for HGF, AdoMet treatment also inhibited the 
proliferative ffect of TGFoL on cultured hepatocytes 
(Figure 3B). 
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Figure 2. (A) Left panel: Dose- 
dependent inhibition by 
AdoMet treatment of HGF-in- 
duced DNA synthesis in rat 
hepatocytes. *P < 0.05, **P 
< 0.01 with respect to cells 
treated with HGF alone. Right 
panel: In the presence of 
AdoMet (4 mmol/ / )  the addi- 
tion of SNAP (200 i~mol/L) 
does not overcome the inhibi- 
tory effect of L-NAME (1 
mmol/L) on HGF-induced DNA 
synthesis. (B) Effect of AdoMet 
(4 mmol/L) on HGF-induced 
DNA synthesis in rat hepato- 
cytes measured at different 
time points. , ,  HGF alone; (3, 
HGF plus AdoMet. 
Growth factor (HGF, epidermal growth factor) treat- 
ment of cultured hepatocytes results in the induction of 
type D cyclin gene expression, 25,26 of which cyclin D1 
has been recognized as the most reliable marker for cell 
cycle (G1 phase) progression in hepatocytes. 2 Now we 
observe that, in the presence of L-NAME, the accumu- 
lation of cyclin D1 protein in response to HGF (25 
ng/mL, 27 hours) was dependent on the concentration of 
L-methionine in the culture medium (Figure 4A), and 
was completely abolished by the simultaneous addition 
of the NO donor SNAP (200 btmol/L). 
This observation suggested that the effect of L-methi- 
onine was dependent on its conversion into AdoMet. 
Accordingly, in the presence of AdoMet (4 mmol/L), 
induction of cyclin D1 and D2 expression by HGF (25 
ng/mL, 27-hour treatment) was substantially reduced 
(Figure 4B). However, activation of ERKI /2  phosphor- 
ylation induced by HGF, which occurs upstream of 
cyclin induction, was not affected by AdoMet treatment 
(Figure 4B). 
Activation of AP1 transcription factor has been shown 
to occur in the liver of rats after PH, 2 and it is known 
that HGF induces AP1 activation in cultured hepato- 
cytes. 24,27 Given the major role played by this transcrip- 
tion factor in the regulation of liver growth during 
regeneration, 28 we tested whether AdoMet could inter- 
fere with its induction by HGF. For this purpose cul- 
tured hepatocytes were treated with HGF (25 ng/mL, 24 
hours) in the presence or absence of AdoMet (4 mmol/L), 
and AP1 binding activity in nuclear protein extracts was 
examined by electrophoretic mobility shift assaysl 
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Figure 3. (A) Induction of DNA synthesis by TGFct (10 ng/mL for 28 
hours) is inhibited by I mmol/L L-methionine when iNOS was inhibited 
by L-NAME (1 mmol/L). *P < 0.01 with respect to cells treated with 
TGFe in the absence of L-NAME. (B) AdoMet (4 mmol/L) inhibits 
TGF~-induced DNA synthesis in rat hepatocytes. *P < 0.05 with 
respect to cells treated with TGFe in the absence of AdoMet. 
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Figure 4. (A) Left panel: Induction of cyclin D1 expression (as determined by Western blot analysis) by HGF (25 ng/mL, 27-hour treatment) in 
rat hepatocytes is modulated bythe concentration of L-methionine in culture medium when iNOS is inhibited by L-NAME (1 mmol/L). The addition 
of a NO donor (SNAP, 200 izmol/L) reverses the inhibitory effect of L-methionine on HGF-induced cyclin D1 expression. Right panel: Quantitation 
of cyclin D1 protein levels in cells treated with HGF in the absence (m) or presence ([3) of L-NAME, or L-NAME plus SNAP (k~). Cyclin D1 protein 
levels found in cells treated with HGF alone were given the arbitrary value of 100%, all values were normalized to actin levels. *P < 0.05 with 
respect to HGF alone in 0.015 mmol/L L-methionine, a* indicates P < 0.05 with respect to HGF plus L-NAME in 0.015 mmol/L L-methionine, 
b* indicates P < 0.05 with respect to HGF plus L-NAME in 0.1 mmol/L L-methionine. (B) AdoMet treatment (4 mmol/L) does not interfere with 
the phosphorylation of ERK1/2 (P-ERK1/2) induced by HGF (25 ng/mL, 30 minutes), but inhibits the induction of cyclin D1 and D2 expression 
elicited by HGF (25 ng/mL, 27-hour treatment) in rat hepatocytes. Actin is shown as a loading control. Quantitation of cyclin D1 and D2 protein 
levels is shown, the levels of these proteins found in control cultures were given the arbitrary value of 1, all values were normalized to actin levels. 
*P < 0.01 with respect to HGF-treated cells. Experiments were performed 3 times in duplicate, representative Western blots are shown. 
As shown in Figure 5A, in the presence of AdoMet, 
HGF-induced AP1 binding activity was attenuated. 
Members of the AP1 family include the c-Jun, JunB, 
JunD, c-Fos, FosB, and Fral proteins. 29 In agreement 
with previous reports, 24 supershift experiments showed 
that HGF-induced AP1 complex contained c-Jun, JunD, 
and Fral proteins (Figure 5B). The composition of this 
complex was altered in the presence of AdoMet, showing 
a drastic reduction in Fral contents (Figure 5B). The 
levels of c-Jun, JunB, JunD, c-Fos, and Fral proteins 
were examined by Western blotting in control and HGF- 
treated hepatocytes (lO-hour treatment) in the presence 
or absence of AdoMet. As previously described, 24no 
major changes were detected in the expression of c-Jun, 
c-Fos, JunB, nor JunD after HGF treatment, whereas 
that of Fral was markedly induced (Figure 5C). When 
HGF treatment was performed in the presence of 
AdoMet (4 mmol/L) the accumulation f Fral protein by 
HGF treatment was blunted (Figure 5C). 
Discussion 
Liver regeneration after PH is a complex and 
multistep rocess of which many aspects still remain 
unknown. A major area of research in this field is the 
identification of the signals that control the onset and 
termination of the hepatocyte proliferative r sponse. Al- 
though HGF is a potent mitogen for cultured hepato- 
cytes, injection of this growth factor in normal rats 
through the portal vein results in a poor mitogenic 
response. *,2 These observations suggest that hepatic pa- 
renchymal cells need to be primed to respond to prolif- 
erative signals. Different experimental pproaches, in- 
cluding the use of knockout animal models, have shown 
that cytokines uch as tumor necrosis factor oL and inter- 
leukin 6 play a key role in the activation of growth- 
regulatory pathways that could be part of this priming 
event. 3°-33 A combination of both cytokines has been 
shown to induce the expression of the iNOS gene, 34 
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Figure 5. (A) Effect of AdoMet (4 mmol/L) on HGF (25 ng/mL, 24-hour 
treatment)-induced AP1 DNA binding activity in rat hepatocytes. Specificity of 
complexes was shown by the addition of lO0-fold molar excess of cold AP1 
consensus oligonucleotide (cons.) and lO0-fold molar excess of mutant AP1 
oligonucleotide (rout.). (B) Identification of the Fos and Jun proteins in the 
APl-binding complexes. Nuclear extracts from control and treated hepato- 
cytes (HGF 25 ng/mL, 24 hours and AdoMet 4 mmol/L as indicated), were 
incubated with 4 Fg of specific antibodies against c-Jun, JunB, JunD, c-Fos, 
or Fral proteins followed by incubation with labeled AP1 probe and analyzed 
by electrophoretic mobility shift assay. Arrowhead indicates supershifted 
bands. (C) Western blot analysis of Jun and Fos proteins in rat hepatocytes 
treated with HGF (25 ng/mL) for 10 hours in the absence or presence of 
AdoMet (4 mmol/L). Actin is shown as a loading control. Experiments were 
performed 3 times in duplicate, representative autoradiograms and blots are 
shown. 
which also occurs in the liver after PH before the onset 
of DNA synthesis) 5 NO production seems to be an 
important response of the remaining liver parenchyma 
because inhibition of iNOS with L-NAME decreases 
hepatocyte proliferation and iNOS knockout mice dis- 
play impaired liver regeneration after PH. 5,6 In iNOS 
knockout mice, hepatocytes undergo necrosis and apo- 
ptosis after PH, indicating that the production of NO 
was essential to protect hepatocytes from death after liver 
resection. 6 Our present observations uggest that, in 
addition to this protective role, NO could also play an 
important function in the sensitization of the hepatocyte 
to the mitogenic action of growth factors such as HGF 
and TGFo~. In agreement with previous reports we 
observed that iNOS expression was induced in cul- 
tured hepatocytes i olated by the collagenase perfusion 
method) 9,2° The proliferative response of these cells to 
HGF was dependent on iNOS activity because its inhi- 
bition with L-NAME resulted in impaired DNA synthe- 
sis. Furthermore, the inhibitory effect of L-NAME was 
overcome by the NO donor SNAP. The growth-promot- 
ing effects of NO are not unique to the liver, and have 
been observed in other cellular backgrounds such as the 
endothelial cell) 6 
The hepatoprotective effect of NO after PH has been 
attributed in part to the nitrosylation and consequent 
inactivation of caspase 3 in Cys-163, a key residue re- 
quired for full proteolytic activity and for the develop- 
ment of apoptosis. 6,37,38 We have observed that the in- 
hibitory effect of L-NAME on HGF-induced hepatocyte 
proliferation was dependent on the concentration of L- 
methionine present in the incubation media, whereas the 
nonmetabolizable analogue D-methionine had no effect. 
As mentioned previously, L-methionine metabolism in 
the liver starts with the formation of AdoMet, a reaction 
catalyzed by MAT I/III, which is a well-characterized 
target for NO in the hepatocyte. We have previously 
shown that MAT I/III is inhibited by NO in vitro and in 
vivo through the nitrosylation of Cys-121, a residue 
unique to the hepatocyte-specific MAT protein (MAT 
I/III), which is absent in the NO-resistant MAT II 
isoenzyme, expressed in all other cell types. 9-12 Inhibi- 
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tion of MAT I/III by NO leads to the reduction of 
intracellular AdoMet levels. 12 Consequently, when MAT 
I/III was protected from NO-mediated inactivation by 
L-NAME we observed higher MAT activity and AdoMet 
contents, and the hepatocyte was rendered refractory to 
HGF-induced DNA synthesis. The observation that this 
effect was dependent on the concentration f methionine 
in the culture medium further suggested that it was 
mediated by AdoMet. Accordingly, when L-methionine 
was substituted by AdoMet we also observed a dose- 
dependent inhibition in the proliferative response to 
HGF. This effect was observed at all time points tested, 
for up to 72 hours of treatment, suggesting that DNA 
synthesis was not merely delayed but was indeed inhib- 
ited. These observations were also extended to TGFot, 
another growth factor for hepatocytes that may be rele- 
vant in the regenerative process of the liver} To identify 
the level at which AdoMet inhibits the mitogenic activ- 
ity of HGF, growth-factor signaling was tested in cul- 
tured hepatocytes. We have previously observed that 
HGF-stimulated p190 Met tyrosine kinase activity is not 
inhibited by AdoMet treatment. 16 Similarly, now we 
report hat the subsequent activation of ERK1/2 by HGF 
is similar in the presence or absence of AdoMet. This 
suggests that AdoMet would act downstream ofERK1/2 
activation, through the regulation of molecular events 
that could include the modulation of ERKI/2 oligomer- 
ization and nuclear translocation, and the regulation of 
phosphatase activity or transcription factor phosphoryla- 
tion, which lies between ERK1/2 activation and induc- 
tion of gene expression) 9 Downstream of ERKI/2 acti- 
vation the up-regulation oftype D cyclins is believed to 
play an important role during the G1 phase in many cell 
types, including hepatocytes, providing a link between 
mitogen signaling and the cell cycle machinery. 2A° Cy- 
clin D1 is induced in rodent liver after PH and in 
regenerating human l iver, 41,42 moreover, its overexpres- 
sion in primary rat hepatocytes causes DNA replication 
in the absence of growth factors and leads to hepatocel- 
lular carcinoma in transgenic mice. 43"44 Our present re- 
suits showing that AdoMet treatment inhibited HGF- 
induced cyclin D1 and D2 expression suggest hat the 
intracellular levels of this metabolite may indeed mod- 
ulate a key response in the mitogenic signaling of HGF. 
Similar results were obtained when HGF treatment was 
performed in the presence of L-NAME and increasing 
concentrations of L-methionine in the culture medium, 
supporting the specificity of the effect of AdoMet and the 
physiological nature of this response. Inhibition of cyclin 
D1 expression by AdoMet also may be relevant regarding 
the antineoplastic properties of AdoMet administration 
in chemically induced rat hepatocarcinoma. 7,'4a7 
Activation of transcription factors such as AP1 and 
nuclear factor-KB (NF-KB) occurs after PH and is 
thought o modulate the expression of genes involved in 
liver regeneration. 2,28 It is known that HGF promotes 
the activation of AP1 and NF-KB in cultured hepato- 
cytes. 24,27 We have recently shown that AdoMet modu- 
lates NF-KB activation in isolated rat hepatocytes 
through the up-regulation of inhibitor kappa B alpha 
(IKBci) levels. 45 Now we have tested the effect of AdoMet 
on HGF-induced AP1 activation. We observed that in 
the presence of AdoMet, the DNA binding activity of 
AP1 stimulated by HGF was attenuated. This effect may 
be caused in part by the marked inhibition of HGF- 
induced Fral expression by AdoMet. In addition, the 
absence of Fral would favor the formation of the less 
active c-Jun/JunD heterodimers. 29 These observations 
could be of significance regarding the inhibition ofcyclin 
D1 expression by AdoMet because this gene can be 
induced through the activation of NF-KB and AP1 tran- 
scription factors. 4° In summary (Figure 6), our observa- 
tions suggest that fluctuations in liver AdoMet contents 
after PH, caused by the NO-mediated inhibition of 
MAT I/III, may represent a novel mechanism that reg- 
ulates the onset of the hepatocyte proliferative response 
HGF 
CELL 
MEMBRANE 
O 
det ~ NUCLEAR 
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PROLIF~ ~d NF~B ~cfivat~ I 
i ST1MUU ~ -'~ [ Cyclin Di/D2 indtmticm ] 
Figure 6. Activation of iNOS and NO production sensitize rat hepato- 
cytes to the mitogenic stimulus of mitogens such as HGF and TGFe 
through the modulation of intracellular AdoMet levels. Increased NO 
production in the hepatocyte, in response to cytokines after PH or 
collagenase perfusion, leads to the specific inactivation of MAT I/1tl 
through S-nitrosylation of cysteine 121, and, consequently, to the 
reduction of intracellular AdoMet levels. When NO generation is pre- 
vented by iNOS inhibitors, and thus MAT I/Ill activity is preserved, the 
proliferative response to HGF is dose-dependently inhibited by L- 
methionine present in the culture medium. Exogenous addition of 
AdoMet mimics the inhibitory effect of L-methionine on HGF-induced 
hepatocyte proliferation, which can be mediated in part through re- 
duced activation of AP1 and NF-KB transcription factors and type D 
cyclin expression. 
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during liver regeneration. Nevertheless, the significance 
of these findings still needs to be tested in an in vivo 
setting. 
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